feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes",https://www.benzinga.com/general/biotech/20/12/18890368/the-daily-biotech-pulse-ziopharm-to-start-blood-cancer-study-chemocentryx-soligenix-slump-on-adve,https://j.mp/3haUoAn
